A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
Public ClinicalTrials.gov record NCT00159653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Xalacom Given In The Evening, Xalatan Given In The Evening, And Timolol Given In The Morning In Patients With Open Angle Glaucoma Or Ocular Hypertension.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure measurements at 8 AM, 10 AM, 4 PM at weeks 2, 6 and 12.
Study identification
- NCT ID
- NCT00159653
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Feb 21, 2021
2005 – 2007
United States locations
- U.S. sites
- 38
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | 85032 | — |
| Pfizer Investigational Site | Poway | California | 92064 | — |
| Pfizer Investigational Site | Redding | California | 96002-2122 | — |
| Pfizer Investigational Site | Redding | California | 96002 | — |
| Pfizer Investigational Site | Danbury | Connecticut | 06810-4004 | — |
| Pfizer Investigational Site | Cape Coral | Florida | 33904 | — |
| Pfizer Investigational Site | Lakeland | Florida | 33805-2440 | — |
| Pfizer Investigational Site | Ormond Beach | Florida | 32174 | — |
| Pfizer Investigational Site | Tampa | Florida | 33603 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30322 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30349 | — |
| Pfizer Investigational Site | Morrow | Georgia | 30260 | — |
| Pfizer Investigational Site | Homewood | Illinois | 60430 | — |
| Pfizer Investigational Site | Overland Park | Kansas | 66213 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71104 | — |
| Pfizer Investigational Site | North Dartmouth | Massachusetts | 02747 | — |
| Pfizer Investigational Site | Saint Joseph | Michigan | 49085 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68506 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68198-5540 | — |
| Pfizer Investigational Site | Newark | New Jersey | 07103-2499 | — |
| Pfizer Investigational Site | Bethpage | New York | 11714-5701 | — |
| Pfizer Investigational Site | New York | New York | 10029-6574 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28210 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28262 | — |
| Pfizer Investigational Site | High Point | North Carolina | 27262 | — |
| Pfizer Investigational Site | Matthews | North Carolina | 28105 | — |
| Pfizer Investigational Site | Wilmington | North Carolina | 28403 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Cranberry Township | Pennsylvania | 16066 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15238-3103 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464-3060 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Pfizer Investigational Site | North Charleston | South Carolina | 29406 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Amarillo | Texas | 79106 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00159653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00159653 live on ClinicalTrials.gov.